Understanding the MDX Test: What Your Results Mean for Duchenne Muscular Dystrophy

The MDX percent blood test quantifies dystrophin protein in blood, aiding diagnosis and monitoring of Duchenne muscular dystrophy (DMD)—an X-linked recessive disorder causing progressive muscle degeneration.

Interpretation

  • Normal dystrophin levels: Rules out DMD.
  • Low/absent dystrophin: Consistent with DMD. Lower levels → more severe phenotype.
  • Intermediate levels: Seen in Becker muscular dystrophy (BMD) or female carriers.

Clinical Utility

  1. Diagnosis: Supports genetic testing (gold standard).
  2. Severity correlation: Dystrophin % predicts age of loss of ambulation, cardiac involvement.
  3. Treatment monitoring: Tracks response to exon-skipping, gene therapy, corticosteroids.
  4. Carrier detection: Female carriers may show 30–70% dystrophin.

Limitations

  • Not standalone; requires genetic confirmation (MLPA, sequencing).
  • Blood dystrophin may not perfectly reflect muscle levels.
  • Interpretation by neuromuscular specialist essential.

Medical Billing - Related Articles